Ingredient Library - Panax Ginseng Root

The Phytochemistry and Dermatological Efficacy of Panax ginseng Root: A Scientific Monograph for Cosmetic Formulators and Informed Consumers

Panax ginseng C.A. Meyer - commonly referred to as Asian, Korean, or Chinese ginseng—belongs to the Araliaceae family and has served as a cornerstone of East Asian pharmacopeias for over two millennia. While its systemic adaptogenic properties have been extensively documented in traditional medicine, modern dermatological research and cosmetic chemistry have isolated specific bioactive fractions within the root that directly modulate cutaneous physiology.

For cosmetic chemists, skincare enthusiasts, and discerning consumers, understanding Panax ginseng requires moving past broad marketing claims ("anti-aging," "revitalizing") to examine its exact molecular architecture, pharmacokinetics upon topical application, and evidence-backed mechanisms of action on human skin.

Botanical Taxonomy and Geographic Chemotypes

Not all "ginseng" listed on a cosmetic International Nomenclature of Cosmetic Ingredients (INCI) label shares identical phytochemistry. True ginseng belongs strictly to the genus Panax, derived from the Greek pan (all) and akos (cure). Within this genus, Panax ginseng (native to the Korean Peninsula, northeastern China, and far eastern Russia) is chemically distinct from Panax quinquefolius (American ginseng) and Panax notoginseng (Sanqi). Furthermore, Eleutherococcus senticosus (Siberian ginseng) is not a Panax species at all; it contains eleutherosides rather than ginsenosides and lacks the specific triterpenoid saponin profile required for targeted dermal receptor modulation.

Within Panax ginseng itself, post-harvest processing dictates the final chemical profile of the cosmetic extract:

- White Ginseng: Harvested at four to six years of age, peeled, and sun-dried or air-dried. This process preserves the native, naturally occurring malonyl-ginsenosides and polar glycosides.

- Red Ginseng (Ginseng Radix Rubra): Steamed at 98–100°C for two to three hours before drying. Thermal processing triggers non-enzymatic hydrolysis and dehydration of the sugar moieties attached to the dammarane skeleton. This converts native polar ginsenosides (such as Rb1, Rb2, Rc, and Rd) into less polar, lower-molecular-weight "rare" ginsenosides—most notably Rg3, Rh1, Rh2, and Rg5. For topical cosmetics, red ginseng extracts are frequently favored because reduced molecular weight and decreased polarity significantly enhance passive diffusion across the lipophilic stratum corneum.

- Black Ginseng: Subjected to nine cycles of steaming and drying, further concentrating deglycosylated secondary metabolites like Compound K and Rk1, yielding potent free-radical scavenging capacity.

Read also: Ginseng and other anti-aging ingredients

Phytochemical Architecture of the Root

The biological activity of Panax ginseng root extract is driven by a complex matrix of secondary metabolites, broadly categorized into saponins and non-saponin fractions.

Triterpenoid Saponins (Ginsenosides)

Ginsenosides are amphiphilic glycosides consisting of a hydrophobic tetracyclic steroid-like aglycone backbone attached to one or more hydrophilic sugar chains (glucose, rhamnose, arabinose, or xylose). Over 150 distinct ginsenosides have been isolated from P. ginseng, classified into two primary structural groups based on the hydroxylation pattern of their dammarane skeleton:

Protopanaxadiols (PPD): Characterized by sugar moieties attached at the C-3 and/or C-20 positions. Key representatives include Rb1, Rb2, Rc, Rd, Rg3, Rh2, and Compound K. PPD-type ginsenosides exhibit strong anti-inflammatory, collagen-stimulating, and barrier-repair properties.

- Protopanaxatriols (PPT): Characterized by a hydroxyl group at C-3 and sugar moieties attached at the C-6 and/or C-20 positions. Key representatives include Re, Rf, Rg1, Rg2, and Rh1. PPT-type ginsenosides predominantly demonstrate microcirculatory enhancement, antioxidant defense, and melanogenesis inhibition.

- Oleanane-Type: Represented almost exclusively by ginsenoside Ro, which possesses a pentacyclic oleanolic acid aglycone and contributes mild surfactant and anti-inflammatory activity.

Non-Saponin Bioactive Fractions

While ginsenosides receive the majority of analytical attention, standardized whole-root extracts contain vital non-saponin compounds that act synergistically in topical formulations:

- Acidic Polysaccharides (Ginsan): High-molecular-weight polymers composed of galacturonic acid, glucuronic acid, galactose, and rhamnose. Topically, these polysaccharides act as humectants, form a breathable hygroscopic film on the epidermis, and stimulate Langerhans cells to bolster cutaneous innate immunity.

- Polyacetylenes: Lipophilic compounds such as panaxynol, panaxydol, and panaxytriol. These molecules exhibit potent antimicrobial activity against cutaneous pathogens (including Cutibacterium acnes and Staphylococcus aureus) and suppress lipid peroxidation in sebum.

• Phenolic Compounds and Flavonoids: Including maltol (formed during the steaming of red ginseng), salicylic acid, vanillic acid, and kaempferol. Maltol acts as an iron chelator and potent hydroxyl radical scavenger, protecting dermal lipids from Fenton-reaction-mediated oxidative stress.

Cutaneous Mechanisms of Action

When formulated at bioactive concentrations and delivered past the epidermal barrier, Panax ginseng root metabolites interact with specific cellular signaling pathways in keratinocytes, dermal fibroblasts, and melanocytes.

Extracellular Matrix Remodeling and Anti-Photoaging

Intrinsic skin aging and extrinsic photoaging (driven primarily by UVA/UVB radiation) converge on a single pathological hallmark: the degradation of the dermal extracellular matrix (ECM). Ultraviolet irradiation generates reactive oxygen species (ROS), which activate cell-surface cytokine and growth factor receptors, triggering the MAPK (Mitogen-Activated Protein Kinase) signaling cascade (ERK, JNK, and p38).

This upregulates the transcription factor AP-1 (Activator Protein-1), which drives the synthesis of Matrix Metalloproteinases (MMPs)—specifically MMP-1 (interstitial collagenase), MMP-3 (stromelysin-1), and MMP-9 (gelatinase B). Concurrently, AP-1 downregulates the TGF-$\beta$/Smad pathway, halting new collagen synthesis.

Ginsenosides intervene at multiple points in this cascade

- Suppression of MMP Expression: In human dermal fibroblasts exposed to UVB, ginsenoside Rb1 and Rg3 inhibit the phosphorylation of JNK and p38 MAPK. By suppressing AP-1 nuclear translocation, they significantly downregulate MMP-1 and MMP-9 mRNA and protein expression, preventing the enzymatic cleavage of triple-helical Type I and Type III collagen fibers.

- Activation of TGF-$\beta$/Smad Signaling: Compound K (the primary deglycosylated metabolite of Rb1) and ginsenoside Rg1 stimulate the phosphorylation of Smad2 and Smad3, restoring the transcription of COL1A1 and COL1A2 genes. In in vitro dermal equivalents, this results in measurable increases in procollagen Type I C-peptide secretion and fibrillin-1 organization.

- Hyaluronic Acid Preservation: Compound K upregulates hyaluronan synthase-2 (HAS2) in epidermal keratinocytes and dermal fibroblasts via Src-dependent Akt/ERK activation, increasing endogenous dermal hyaluronic acid content and improving tissue turgor.

Melanogenesis Regulation and Hyperpigmentation

Hyperpigmentation disorders—such as solar lentigines, melasma, and post-inflammatory hyperpigmentation (PIH)—stem from dysregulated melanin synthesis within epidermal melanocytes. This process is governed by the rate-limiting enzyme tyrosinase, alongside tyrosinase-related proteins TRP-1 and TRP-2, all under the transcriptional control of MITF (Microphthalmia-associated Transcription Factor).

Panax ginseng modulates pigmentation without the cytotoxic melanocyte damage associated with hydroquinone:

- Direct Tyrosinase Inhibition: Ginsenoside Rh1, Rg3, and p-coumaric acid isolated from ginseng root act as competitive or mixed-type inhibitors of mushroom and human tyrosinase, blocking the hydroxylation of L-tyrosine to L-DOPA and the subsequent oxidation of L-DOPA to dopaquinone.

- MITF Downregulation: Ginsenoside Rg3 activates the ERK signaling pathway in melanocytes, which promotes the ubiquitin-mediated proteasomal degradation of MITF. Lower intracellular MITF levels reduce the downstream transcription of tyrosinase, TRP-1, and TRP-2.

- Melanosome Transfer Inhibition: Ginsenoside F1 (a metabolite of Re and Rg1) reduces dendrite extension in activated melanocytes by modulating Rho-family GTPases, thereby limiting the physical transfer of mature melanosomes to surrounding basal keratinocytes.

Epidermal Barrier Integrity and Inflammatory Modulation

A compromised stratum corneum is characterized by depleted intercellular lipids (ceramides, cholesterol, free fatty acids), reduced natural moisturizing factor (NMF), and chronic subclinical inflammation ("inflammaging").

- Cornified Envelope Maturation: Ginsenoside Rb1 and red ginseng extract upregulate the expression of filaggrin, involucrin, and loricrin in differentiating keratinocytes. Filaggrin is subsequently proteolyzed into hygroscopic amino acids (urocanic acid and pyrrolidone carboxylic acid), directly increasing stratum corneum hydration and maintaining the acidic skin mantle (pH 4.5–5.5).

- Ceramide Biosynthesis: Topical application of fermented ginseng extracts stimulates serine palmitoyltransferase (SPT) and $\beta$-glucocerebrosidase, accelerating the de novo synthesis and extracellular processing of ceramides, which reduces transepidermal water loss (TEWL).

- NF-$\kappa$B Inhibition: Chronic cutaneous inflammation is mediated by the NF-$\kappa$B (Nuclear Factor kappa-light-chain-enhancer of activated B cells) pathway. Ginsenosides Rg1, Rb1, and Rg3 prevent the degradation of the inhibitory protein I$\kappa$B$\alpha$, trapping NF-$\kappa$B in the cytoplasm. This suppresses the release of pro-inflammatory cytokines—specifically IL-1$\alpha$, IL-6, IL-8, and TNF-$\alpha$—as well as COX-2 and iNOS, making ginseng valuable in formulations targeting rosacea-prone, sensitized, or post-procedure skin.

Cutaneous Microcirculation and Follicular Biology

In periorbital skincare and trichology (scalp care), Panax ginseng is utilized for its hemodynamic and growth-factor-modulating properties. Ginsenoside Rg1 stimulates endothelial nitric oxide synthase (eNOS) via the PI3K/Akt pathway, increasing local nitric oxide (NO) production. This induces localized vasodilation, improving capillary blood flow, nutrient delivery, and lymphatic drainage—mechanisms that clinically reduce vascular periorbital dark circles and morning edema.

In the hair follicle, ginsenoside Rb1 and Rg3 promote the proliferation of human dermal papilla cells (hDPCs) by upregulating VEGF (Vascular Endothelial Growth Factor) and Bcl-2 (an anti-apoptotic protein) while downregulating TGF-$\beta1$ (which triggers the catagen regression phase) and inhibiting 5$\alpha$-reductase, the enzyme responsible for converting testosterone into follicle-miniaturizing dihydrotestosterone (DHT).

Pharmacokinetics and Formulation Science: Overcoming the Dermal Barrier

A critical limitation of many botanical extracts in cosmetics is poor bioavailability. Native ginsenosides such as Rb1 have a molecular weight of 1,109.29 Da and a high topological polar surface area due to their four glucose moieties. According to the 500 Dalton rule of skin penetration, molecules exceeding 500 Da exhibit negligible passive diffusion across an intact stratum corneum.

To translate in vitro efficacy into clinical results, cosmetic chemists employ specific extraction and delivery strategies:

- Biotransformation (Fermentation): Culturing Panax ginseng root extract with probiotic strains such as Lactobacillus plantarum, Bifidobacterium longum, or Aspergillus niger enzymatically cleaves the outer glucose chains via $\beta$-glucosidase. This converts bulky native ginsenosides (Rb1, Rb2, Rc) into low-molecular-weight aglycones and monoglycosides like Compound K (MW: 622.87 Da) and Rh2 (MW: 622.87 Da), drastically increasing lipophilicity ($\log P$) and transdermal flux.

- Liposomal and Niosomal Encapsulation: Encapsulating standardized ginseng extracts within phospholipid bilayers (liposomes) or non-ionic surfactant vesicles (niosomes) protects thermolabile and oxidation-prone ginsenosides from degradation while facilitating fusion with stratum corneum intercellular lipids.

- Subcritical Water and Supercritical $\text{CO}_2$ Extraction: Traditional ethanol-water extraction yields broad-spectrum extracts, whereas supercritical $\text{CO}_2$ extraction isolates lipophilic polyacetylenes and phytosterols without solvent residues, ideal for anhydrous facial oils and barrier balms.

- Formulation pH and Stability: Ginsenosides undergo acid-catalyzed hydrolysis at pH values below 4.0 and alkaline degradation above pH 8.0. Optimal cosmetic stability is achieved within a pH window of 5.0 to 6.5, which aligns seamlessly with the physiological pH of human skin.

Practical Guide for Consumers and Formulators: Evaluating Ginseng Cosmetics

Because cosmetic regulations do not require brands to disclose the exact ginsenoside standardization of an extract, products containing "ginseng" vary wildly from trace "fairy-dusted" water extracts (0.001%) to clinically active formulations (1% to 5% standardized extract).

Decoding the INCI Label

When evaluating a cosmetic product, inspect the ingredient deck for specific nomenclature that indicates extract quality and processing:

- Panax Ginseng Root Extract: The standard designation for hydroglyceric or hydroalcoholic extracts. Look for its placement in the upper-to-middle third of the ingredient list (above phenoxyethanol or fragrance, which are typically dosed at or below 1%).

- Panax Ginseng Root Water: A hydrosol obtained via steam distillation. While soothing and mildly hydrating, hydrosols contain only volatile aromatic compounds and trace water-soluble fractions; they lack non-volatile triterpenoid saponins (ginsenosides). Do not rely on ginseng water alone for anti-aging or collagen stimulation.

- Lactobacillus/Panax Ginseng Root Ferment Filtrate: Indicates enzymatic fermentation. This is a strong marker for higher bioavailability of rare ginsenosides (Compound K, Rh1, Rh2) and improved tolerance for sensitive skin.

- Hydrolyzed Ginseng Saponins: Indicates chemical or enzymatic cleavage of native saponins into smaller, skin-permeable fractions.

Synergistic Ingredient Pairings

In evidence-based formulation, Panax ginseng functions exceptionally well as a biological amplifier alongside established actives:

- With Retinoids (Retinol, Retinaldehyde): Retinoids accelerate epidermal turnover and stimulate collagen but frequently induce retinoid dermatitis (erythema, scaling, barrier disruption) via IL-1$\alpha$ and IL-8 release. Ginsenoside Rb1 and acidic polysaccharides suppress these inflammatory cytokines and upregulate filaggrin, mitigating irritation without blunting retinoid receptor (RAR/RXR) efficacy.

- With L-Ascorbic Acid and Vitamin E: Ginseng's phenolic fractions (maltol, ferulic acid) regenerate oxidized $\alpha$-tocopherol and provide complementary metal-chelating antioxidant defense, broadening photoprotection beneath daytime sunscreens.

- With Niacinamide (Vitamin B3): While niacinamide inhibits melanosome transfer via PAR-2 receptor modulation, ginsenosides Rg3 and Rh1 directly inhibit tyrosinase and degrade MITF. Combining the two targets hyperpigmentation across three distinct biochemical checkpoints.

- With Caffeine and Peptides (Periorbital Care): Caffeine induces vasoconstriction to reduce fluid pooling, whereas ginsenoside Rg1 improves capillary microcirculation and dermal thickness, addressing both vascular and structural causes of under-eye darkness.

Buy here

Safety, Toxicology, and Contraindications

Topical Panax ginseng root extract demonstrates an exemplary safety profile. Safety assessments by the Cosmetic Ingredient Review (CIR) Expert Panel confirm that Panax ginseng root extracts are non-irritating, non-sensitizing, and non-phototoxic at standard cosmetic concentrations (up to 5%).

However, two practical caveats apply to clinical and consumer use:

- Phytoestrogenic Activity: Certain ginsenosides (notably Rb1 and Rg1) exhibit weak binding affinity for estrogen receptors ($\text{ER}\alpha$ and $\text{ER}\beta$). While systemic absorption from topical facial cosmetics is negligible, individuals with estrogen-receptor-positive malignancies or severe melasma triggered by hormonal fluctuations should consult a dermatologist before applying high-concentration transdermal ginseng products over large body surface areas.

Whole-Root vs. Purified Extracts in Reactive Skin: Unrefined, crude root extracts contain trace sesquiterpenes and polyacetylenes that, in rare cases, may trigger contact dermatitis in individuals with severe allergies to plants in the Araliaceae family (such as English ivy, Hedera helix). Highly purified or fermented extracts remove these potential sensitizers.

Summary of Clinical Selection Criteria

To maximize dermatological return on investment when selecting or formulating Panax ginseng skincare:

- Prioritize Standardized or Fermented Extracts: Seek products specifying Red Ginseng, Fermented Ginseng Filtrate, or Hydrolyzed Ginseng Saponins rather than plain ginseng root water, ensuring the presence of low-molecular-weight, skin-permeable ginsenosides (Rg3, Rh1, Compound K).

- Match the Vehicle to the Target: Use aqueous serums or essences containing fermented ginseng and niacinamide for epidermal brightening and barrier repair; select lipid-rich emulsions or liposomal creams for dermal anti-photoaging and transdermal delivery of protopanaxadiols.

- Commit to Chronological Consistency: Because ginsenoside-mediated collagen synthesis (TGF-$\beta$/Smad activation) and epidermal turnover require full keratinocyte and fibroblast remodeling cycles, measurable improvements in skin elasticity, wrinkle depth, and melanin index typically require 8 to 12 weeks of twice-daily application.